Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXG3IJ
|
||||
| Drug Name |
6-{1-[2-(3a,7a-Dihydro-1H-indol-4-yloxy)-ethyl]-piperidin-4-yloxy}-4H-benzo[1,4]oxazin-3-one
|
||||
| Synonyms |
CHEMBL2113021
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H25N3O4
|
||||
| Canonical SMILES |
O=C1COc2ccc(OC3CCN(CCOc4cccc5[nH]ccc45)CC3)cc2N1
|
||||
| InChI |
InChI=1S/C23H25N3O4/c27-23-15-29-22-5-4-17(14-20(22)25-23)30-16-7-10-26(11-8-16)12-13-28-21-3-1-2-19-18(21)6-9-24-19/h1-6,9,14,16,24H,7-8,10-13,15H2,(H,25,27)
|
||||
| InChIKey |
YUGGSPPVYUNNGK-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.